Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1683
https://www.valueinhealthjournal.com/article/S1098-3015(14)03613-4/fulltext
Title :
Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03613-4&doi=10.1016/j.jval.2014.08.1683
First page :
A530
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1153